Tavalisse
PHONETIC PRONUNCIATION: Tavalisse
Description
Tavalisse: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Tavalisse (fostamatinib disodium hexahydrate) is a medication used to treat a rare and serious blood disorder known as Chronic Immune Thrombocytopenia (ITP). This disorder is characterized by a low platelet count, which can lead to abnormal bleeding or bruising. Uses Tavalisse works by blocking the activity of the spleen tyrosine kinase (SYK) enzyme, which is involved in the destruction of platelets in patients with ITP. As a result, the number of platelets in the blood increases, reducing the risk of bleeding. The medication is intended for adults who have had an insufficient response to other treatments for ITP. It is only available with a doctor's prescription. Dosage Tavalisse is taken orally with or without food, as directed by a healthcare provider. The recommended dose is 100 mg twice daily, which can be increased to 150 mg twice daily if platelet counts do not improve after four weeks. Patients should not exceed a daily dose of 300 mg, and the medication should not be taken with certain other drugs that can interact with Tavalisse. Demographic Tavalisse is intended for use by adults who have been diagnosed with ITP. This condition is more common in women than men and is often diagnosed in people between the ages of 30 and 50. The medication is not currently approved for use in children. Side Effects Like all medications, Tavalisse may cause some side effects. These can include headache, nausea, diarrhea, fatigue, respiratory infections, high blood pressure, liver problems, and bleeding. Patients should contact their healthcare provider immediately if they experience any of the following symptoms while taking Tavalisse: - Difficulty breathing or swelling of the face, lips, tongue, or throat - Unusual bleeding or bruising - Jaundice (yellowing of the skin or eyes) - Severe stomach pain or persistent vomiting Interactions Tavalisse may interact with other medications a person is taking, including over-the-counter drugs and herbal supplements. Patients should inform their healthcare provider of all medications and supplements they are taking before starting Tavalisse. The medication should not be taken with strong inhibitors or inducers of the cytochrome P450 enzyme system, which can affect the way the body processes Tavalisse. Generic options Tavalisse is currently only available as a brand-name medication and there is no generic form of the drug. However, patients with ITP should talk to their healthcare provider about other treatment options and any possible generic alternatives. In conclusion, Tavalisse is a medication used to treat ITP by increasing the number of platelets in the blood. Patients should follow their healthcare provider's instructions regarding dosage, and be aware of potential side effects and drug interactions. While there is no generic version of Tavalisse, patients should discuss other treatment options that may be available.
Faq for Tavalisse
Tavalisse (fostamatinib disodium hexahydrate) is a medication used for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to previous treatments.
Tavalisse works by inhibiting the activity of an enzyme called spleen tyrosine kinase (SYK) in platelets and certain immune cells. This helps to increase platelet counts in patients with chronic ITP.
Tavalisse is available as tablets and should be taken orally, usually twice daily. It can be taken with or without food. The exact dosage and duration of treatment will be determined by your healthcare provider.
The most common side effects of Tavalisse include diarrhea, hypertension (high blood pressure), nausea, dizziness, respiratory infection, fatigue, and muscle spasms. It is important to discuss any side effects with your doctor.
Tavalisse is not recommended for use during pregnancy as it may harm the fetus. It is also not known if Tavalisse passes into breast milk, so breastfeeding mothers should discuss the potential risks with their healthcare provider.
The effectiveness of Tavalisse varies from person to person. Some patients may experience an increase in platelet count within a few weeks, while for others it may take longer. Your doctor will monitor your response to treatment and determine the appropriate duration of therapy.
Some medications, such as strong CYP3A4 inhibitors or inducers, may interact with Tavalisse and affect its efficacy or increase the risk of side effects. It is important to inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal supplements.
During the initial period of treatment, your doctor will closely monitor your platelet count. After achieving a stable platelet count, regular monitoring will still be required. The frequency of platelet count checks will be determined by your healthcare provider.
Tavalisse is not a cure for chronic ITP. It is aimed at managing the symptoms and increasing platelet counts. The decision to continue or stop treatment with Tavalisse will be based on your response and your doctor's evaluation of your condition.